Smartleaf Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Smartleaf Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71K	Hold	278	–	–	﹤0.01%	2988
2026 Q1	$1.85K	Sell	278 -1,553	-85%	-$12K	﹤0.01%	2979
2025 Q4	$12.9K	Hold	1,831	–	–	﹤0.01%	2273
2025 Q3	$8.99K	Hold	1,831	–	–	﹤0.01%	2161
2025 Q2	$8.75K	Buy	1,831 +1,712	+1,439%	+$7.49K	﹤0.01%	1870
2025 Q1	$558	Hold	119	–	–	﹤0.01%	2685
2024 Q4	$568	Hold	119	–	–	﹤0.01%	2768
2024 Q3	$555	Buy	119 +52	+78%	+$279	﹤0.01%	2770
2024 Q2	$389	Buy	+67	New	+$346	﹤0.01%	2594

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's VNDA Position: Q2 2026 in Review

Smartleaf Asset Management held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 278 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Smartleaf Asset Management first reported a position in VNDA in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.9K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Smartleaf Asset Management held 278 shares of Vanda Pharmaceuticals worth $1.71K as of Q2 2026.
Smartleaf Asset Management left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
Vanda Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2988 holding.
Smartleaf Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Smartleaf Asset Management's Vanda Pharmaceuticals position peaked at $12.9K in Q4 2025.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.